Oncorus Financials
ONCRDelisted Stock | USD 0.04 0.01 14.71% |
Oncorus |
Understanding current and past Oncorus Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Oncorus' financial statements are interrelated, with each one affecting the others. For example, an increase in Oncorus' assets may result in an increase in income on the income statement.
Oncorus Stock Summary
Oncorus competes with Pyxis Oncology, Zura Bio, Altamira Therapeutics, Elevation Oncology, and Cardio Diagnostics. Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Oncorus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US68236R1032 |
Business Address | 50 Hampshire Street, |
Sector | Healthcare |
Industry | Biotechnology |
Benchmark | Dow Jones Industrial |
Website | www.oncorus.com |
Phone | 857 320 6400 |
Currency | USD - US Dollar |
Oncorus Key Financial Ratios
Oncorus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oncorus's current stock value. Our valuation model uses many indicators to compare Oncorus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oncorus competition to find correlations between indicators driving Oncorus's intrinsic value. More Info.Oncorus is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Oncorus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Oncorus Market Pulse
Quote | 0.0435 |
Change(%) | 14.71 |
Change | 0.01 |
Open | 0.051 |
Low | 0.038 |
High | 0.06 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Oncorus is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Oncorus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Oncorus' financials are consistent with your investment objective using the following steps:- Review Oncorus' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Oncorus' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Oncorus' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Oncorus' stock is overvalued or undervalued.
Oncorus November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Oncorus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oncorus. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oncorus based on widely used predictive technical indicators. In general, we focus on analyzing Oncorus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oncorus's daily price indicators and compare them against related drivers.
Information Ratio | (0.16) | |||
Maximum Drawdown | 120.67 | |||
Value At Risk | (21.20) | |||
Potential Upside | 10.0 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Oncorus Stock
If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
CEOs Directory Screen CEOs from public companies around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stocks Directory Find actively traded stocks across global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |